Evidence map›Paper›PMID 39420340›Full record

ArticleCardiovascular diabetology2024

Reduced circulating CD63

Brachyahu M Kestecher, Krisztina Németh, Sayam Ghosal, Nabil V Sayour, Tamás G Gergely, Bernadett R Bodnár, András I Försönits, Barbara W Sódar, Johannes Oesterreicher, Wolfgang Holnthoner and 5 more

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Extracellular Vesicles as Emerging Regulators in Ischemic and Hypertrophic Cardiovascular Diseases: A Review of Pathogenesis and Therapeutics.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  8. Article
  9. Article
  10. Influence of hemolysis, lipemia and bilirubin on biobank sample quality- origin and interference in the use for extracellular vesicle (EV) and MiRNA analyses.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Brachyahu M KestecherInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Krisztina NémethInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Sayam GhosalInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Nabil V SayourDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Tamás G GergelyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Bernadett R BodnárInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
András I FörsönitsInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Barbara W SódarInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Johannes OesterreicherLudwig-Boltzmann-Institute for Traumatology, The Research Centre in Cooperation with AUVA, Vienna, Austria.
Wolfgang HolnthonerLudwig-Boltzmann-Institute for Traumatology, The Research Centre in Cooperation with AUVA, Vienna, Austria.
Zoltán V VargaDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Zoltán GiriczDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Péter FerdinandyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Edit I BuzásInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Xabier OsteikoetxeaInstitute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary. xabieruf@gmail.com.

Funding

EKÖP EKÖP-2024-237European Commission RRF-2.3.121-2022-00003Horizon 2020 Framework Programme 2019-2.1.7-ERA-NET-2021-00015Horizon 2020 Framework Programme 739593Hungarian Scientific Research Fund OTKA FK 147023Hungarian Scientific Research Fund TKP2021-EGA-23NVKP NVKP_16-1-2016-0004VEKOP VEKOP-2.3.2-162016-00002
6 · The paper itself

Abstract

aimsThe association and co-isolation of low-density lipoproteins (LDL) and extracellular vesicles (EVs) have been shown in blood plasma. Here we explore this relationship to better understand the role of EVs in atherogenesis. METHODS AND

resultsWild type (WT), PCSK9

conclusionsThis research demonstrates an inverse relationship between circulating EVs and cholesterol, making EVs a potential marker for cardiovascular disease (CVD). HFD causes reduced cardiac function, but atherosclerotic development is slowly progressing in hypercholesterolaemic models and only observed with old animals. These results also bring further evidence for the benefit of using of PCSK9 inhibitors as therapeutic agents in CVD.

Indexed as

AtherosclerosisBiomarkersDiet, High-FatDisease Models, AnimalExtracellular VesiclesHypercholesterolemiaProprotein Convertase 9Receptors, LDLTetraspanin 30AgedAnimalsAortic DiseasesCase-Control StudiesCholesterolFemaleHumansBiomarkersCd63 protein, mouseCholesterolLDLR protein, humanPCSK9 protein, humanPcsk9 protein, mouseProprotein Convertase 9Receptors, LDLTetraspanin 30

Identifiers

PMID39420340
PMCPMC11487797

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.